dipyridamole has been researched along with Hibernation, Myocardial in 20 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "With dobutamine, the stimulus is a beta-receptor mediated effect on myocardial cell, which is later matched by an increase in flow." | 2.39 | Detection of viable myocardium by dobutamine and dipyridamole stress echocardiography. ( Bento de Sousa, MJ; de Moura Duarte, LF; Picano, E; Pingitore, A; Sicari, R, 1994) |
| "Only in stunned myocardium (in the setting of single-vessel disease), dipyridamole tends to normalize deformation." | 1.35 | The quantification of dipyridamole induced changes in regional deformation in normal, stunned or infarcted myocardium as measured by strain and strain rate: an experimental study. ( Bijnens, B; Boettler, P; Claus, P; D'hooge, J; Marciniak, A; Marciniak, M; McLaughlin, M; Rademakers, F; Streb, W; Sutherland, GR, 2008) |
| "Myocardial stunning is a lingering contractile dysfunction that occurs after a brief ischemic insult." | 1.33 | Importance of gated imaging in both phases of myocardial perfusion SPECT: myocardial stunning after dipyridamole infusion. ( Kakhki, VD; Sadeghi, R; Yousefi, A; Zakavi, SR, 2006) |
| "Using gated 99mTc-MIBI SPECT, stunned myocardium was found on 1-h poststress SPECT compared with normal resting wall motion found on rest gated SPECT on the next day." | 1.31 | Transient prolonged stunning induced by dipyridamole and shown on 1- and 24-hour poststress 99mTc-MIBI gated SPECT. ( Chung, JK; Lee, DS; Lee, MC; Lee, MM; Yeo, JS, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bestetti, A | 1 |
| Cuko, B | 1 |
| Gasparini, M | 1 |
| De Servi, S | 1 |
| Lin, WL | 1 |
| Wang, SY | 1 |
| Shiau, YC | 1 |
| Wu, YW | 1 |
| Bombardini, T | 1 |
| Gherardi, S | 1 |
| Leone, O | 1 |
| Sicari, R | 2 |
| Picano, E | 2 |
| Kasprzak, JD | 1 |
| Nihoyannopoulos, P | 1 |
| Vanoverschelde, JL | 1 |
| Slart, RH | 1 |
| Zeebregts, CJ | 1 |
| Hillege, HL | 1 |
| de Sutter, J | 1 |
| Dierckx, RA | 1 |
| van Veldhuisen, DJ | 1 |
| Zijlstra, F | 1 |
| Tio, RA | 1 |
| Marwick, TH | 1 |
| Hung, GU | 1 |
| Chen, CP | 1 |
| Yang, KT | 1 |
| Kakhki, VD | 1 |
| Zakavi, SR | 1 |
| Sadeghi, R | 1 |
| Yousefi, A | 1 |
| Marciniak, M | 1 |
| Claus, P | 1 |
| Streb, W | 1 |
| Marciniak, A | 1 |
| Boettler, P | 1 |
| McLaughlin, M | 1 |
| D'hooge, J | 1 |
| Rademakers, F | 1 |
| Bijnens, B | 1 |
| Sutherland, GR | 1 |
| Mosca, SM | 1 |
| Gelpi, RJ | 1 |
| Cingolani, HE | 1 |
| Bento de Sousa, MJ | 1 |
| de Moura Duarte, LF | 1 |
| Pingitore, A | 1 |
| Kim, S | 1 |
| Yamabe, H | 1 |
| Yokoyama, M | 1 |
| Mohr-Kahaly, S | 1 |
| Wagner, S | 1 |
| Meyer, J | 1 |
| Piérard, L | 1 |
| Hoffer, E | 1 |
| Johnson, LL | 1 |
| Verdesca, SA | 1 |
| Aude, WY | 1 |
| Xavier, RC | 1 |
| Nott, LT | 1 |
| Campanella, MW | 1 |
| Germano, G | 1 |
| Mota, P | 1 |
| Lee, DS | 2 |
| Yeo, JS | 2 |
| Chung, JK | 2 |
| Lee, MM | 1 |
| Lee, MC | 2 |
| Borges, AC | 1 |
| Richter, WS | 1 |
| Witzel, M | 1 |
| Witzel, C | 1 |
| Grohmann, A | 1 |
| Baumann, G | 1 |
| Paeng, JC | 1 |
| Noh, CI | 1 |
| Kim, YK | 1 |
4 reviews available for dipyridamole and Hibernation, Myocardial
| Article | Year |
|---|---|
Stress echocardiography.
Topics: Cardiotonic Agents; Coronary Artery Disease; Coronary Stenosis; Dipyridamole; Dopamine; Echocardiogr | 2003 |
Detection of viable myocardium by dobutamine and dipyridamole stress echocardiography.
Topics: Coronary Circulation; Dipyridamole; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; | 1994 |
[Detection of myocardial viability: role of stress echocardiography].
Topics: Dipyridamole; Dobutamine; Echocardiography; Humans; Myocardial Contraction; Myocardial Ischemia; Myo | 1997 |
[Stress echocardiography in myocardial infarct].
Topics: Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography; Humans; Myocardial Contraction; Myoc | 1998 |
1 trial available for dipyridamole and Hibernation, Myocardial
| Article | Year |
|---|---|
Transplant of stunned donor hearts rescued by pharmacological stress echocardiography: a "proof of concept" report.
Topics: Adult; Dipyridamole; Echocardiography; Exercise Test; Female; Graft Rejection; Heart Transplantation | 2013 |
15 other studies available for dipyridamole and Hibernation, Myocardial
| Article | Year |
|---|---|
Better characterization of dipyridamole-induced myocardial stunning by systolic wall thickening. A gated perfusion SPECT study.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Dipyridamole; Female; Human | 2020 |
The clinical usefulness of phase analysis in detecting coronary artery disease using dipyridamole thallium-201-gated myocardial perfusion imaging with a cadmium-zinc-telluride camera.
Topics: Aged; Cadmium; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Angiograp | 2020 |
[Viable or nonviable--a problem of everyday life].
Topics: Cell Survival; Coronary Stenosis; Dipyridamole; Dobutamine; Echocardiography, Stress; Humans; Myocar | 2010 |
Myocardial ischaemia and viability: the pivotal role of echocardiography.
Topics: Animals; Cardiotonic Agents; Contrast Media; Coronary Circulation; Diagnosis, Differential; Dipyrida | 2011 |
Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
Topics: Aged; Ammonia; Capillaries; Coronary Artery Disease; Coronary Circulation; Dipyridamole; Endpoint De | 2011 |
Incremental value of ischemic stunning on the detection of severe and extensive coronary artery disease in dipyridamole Tl-201 gated myocardial perfusion imaging.
Topics: Aged; Coronary Artery Disease; Dipyridamole; Humans; Male; Myocardial Reperfusion; Myocardial Stunni | 2005 |
Importance of gated imaging in both phases of myocardial perfusion SPECT: myocardial stunning after dipyridamole infusion.
Topics: Aged; Dipyridamole; Female; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Infusions, Intraveno | 2006 |
The quantification of dipyridamole induced changes in regional deformation in normal, stunned or infarcted myocardium as measured by strain and strain rate: an experimental study.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Coronary Stenosis; Dipyridamole; Disease Models, | 2008 |
Adenosine and dipyridamole mimic the effects of ischemic preconditioning.
Topics: Adaptation, Physiological; Adenosine; Animals; Blood Pressure; Dipyridamole; Myocardial Ischemia; My | 1994 |
Impaired coronary circulation in acute myocardial infarction: a dipyridamole-thallium-201 study.
Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Dipyridamole; Female; Heart; Humans; Male; Mid | 1997 |
Relationship between coronary lesion morphology and inducible wall motion abnormalities.
Topics: Coronary Disease; Dipyridamole; Echocardiography; Humans; Myocardial Contraction; Myocardial Infarct | 1997 |
Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms.
Topics: Dipyridamole; Exercise Test; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; | 1997 |
Transient prolonged stunning induced by dipyridamole and shown on 1- and 24-hour poststress 99mTc-MIBI gated SPECT.
Topics: Coronary Disease; Dipyridamole; Female; Gated Blood-Pool Imaging; Humans; Image Processing, Computer | 2000 |
Combined dipyridamole and dobutamine echocardiography in myocardial hibernation: comparison with thallium uptake in patients after percutaneous transluminal coronary revascularization under circulatory support.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Coronary Disease; Dipyridamole; Dob | 2001 |
Septal stunning by dipyridamole stress shown on quantitative gated perfusion SPECT in a child with hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Child; Dipyridamole; Gated Blood-Pool Imaging; Heart Septum; Humans; M | 2002 |